title: Reversible cerebellar toxicity during treatment with ornidazole: the first case report.
authors.forename: O
authors.initials: O
authors.lastname: Taskapilioglu
authors.forename: M
authors.initials: M
authors.lastname: Seferoglu
authors.forename: E
authors.initials: E
authors.lastname: Kaygili
authors.forename: B
authors.initials: B
authors.lastname: Hakyemez
authors.forename: M
authors.initials: M
authors.lastname: Zarifoglu
mesh_terms: D000563:Amebicides / Q000627:therapeutic use / Q000633:toxicity*; D002524:Cerebellar Ataxia / Q000139:chemically induced / Q000175:diagnosis; D002526:Cerebellar Diseases / Q000139:chemically induced* / Q000175:diagnosis; D002529:Cerebellar Nuclei / Q000187:drug effects / Q000473:pathology; D003337:Corpus Callosum / Q000187:drug effects / Q000473:pathology; D038524:Diffusion Magnetic Resonance Imaging; D004359:Drug Therapy, Combination; D004401:Dysarthria / Q000139:chemically induced / Q000175:diagnosis; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D009950:Ornidazole / Q000627:therapeutic use / Q000633:toxicity*; D010437:Peptic Ulcer / Q000188:drug therapy*; D011149:Pons / Q000187:drug effects / Q000473:pathology; D013681:Tegmentum Mesencephali / Q000187:drug effects / Q000473:pathology; D055815:Young Adult
chemical_list: D000563:Amebicides; D009950:Ornidazole